Wako Diagnostics offers biomarkers AFP-L3 (lectin-reactive alpha-fetoprotein) and DCP (des-gamma-carboxy prothrombin) to aid in the early detection of hepatocellular carcinoma (HCC) in at-risk patients. Both blood tests are 510(k)-cleared, CMS reimbursed, and available at major reference laboratories.
Brands: Wako Diagnostics is dedicated to develop and supply IVD and life science products for the improvement of patient survival and quality of life through innovation and technology.
DDW Tracks Basic Science, Microbiome in Gastrointestinal and Liver Diseases
Does your company only service US attendees? Yes
Is your company a new exhibiting company? Yes